Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
about
Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel diseaseThe versatility of oligonucleotides as potential therapeutics.Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy.Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform.Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity.Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma.Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells.Preventive Effect of TU-100 on a Type-2 Model of Colitis in Mice: Possible Involvement of Enhancing Adrenomedullin in Intestinal Epithelial Cells.Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.Effect of recombinant Lactobacillus casei expressing interleukin-10 in dextran sulfate sodium-induced colitis mice.The effect of melatonin on plasma markers of inflammation and on expression of nuclear factor-kappa beta in acetic acid-induced colitis in the rat.Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis.Dietary lactoferrin does not prevent dextran sulfate sodium induced murine intestinal lymphocyte death.Expression of hepatic cytochrome P450 in a mouse model of ulcerative colitis changes with pathological conditions.
P2860
Q33690892-DEA0C3A1-D2FC-4A17-AAC0-62051599EEC1Q34233126-44780943-45E6-4E3B-80A7-4D9F603A6385Q34253078-2DD98D99-EF5C-4E75-93C8-1277DFF475F0Q34487187-4B3708AA-D2E0-41DC-85AF-D6DE1044A04CQ36897394-0A51B4BB-9203-47A2-8A95-3F1AEA3BA544Q37010500-669A12DC-C9AB-4DDF-804B-F67302CEE7ECQ37515656-072F754F-C57E-40B7-9320-92E88A6A07B3Q37950418-054752E3-E224-4CB2-B240-5EED4075F9C9Q38644746-75509CE7-B693-4E78-BCA4-6F2F3C533773Q39616150-6CA601F9-B419-41F0-BDFE-5BC5B722F664Q40111828-3BA0C1A9-07E4-499E-8F82-D5A838F93426Q41855658-1BF5B921-D412-4316-8BCA-C70DC412B5A2Q42376083-2D301BF4-200B-4E63-BF71-0B3C387EA1FEQ43907875-76B578FB-2018-4DBF-ADC2-C0005EC71D27Q46343201-415B7FA5-3466-44FC-A9B1-172E8298500AQ47345804-EA3ECB0A-A0F2-4CD0-86CB-E58DA72BE362Q51699467-3E3BCD0F-8577-43F1-8D2A-61C1A87B60E8Q53544919-BA44353D-F798-4A64-9E16-3E6EB74AE8FA
P2860
Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Non-viral delivery of nuclear ...... d restores tissue homeostasis.
@ast
Non-viral delivery of nuclear ...... d restores tissue homeostasis.
@en
type
label
Non-viral delivery of nuclear ...... d restores tissue homeostasis.
@ast
Non-viral delivery of nuclear ...... d restores tissue homeostasis.
@en
prefLabel
Non-viral delivery of nuclear ...... d restores tissue homeostasis.
@ast
Non-viral delivery of nuclear ...... d restores tissue homeostasis.
@en
P2093
P2860
P356
P1433
P1476
Non-viral delivery of nuclear ...... d restores tissue homeostasis.
@en
P2093
Brian Schryver
Carlos Lorenzana
Christi Parham
Christopher G De Vry
Jennifer Hoffman
Laszlo Komuves
Leslie M McEvoy
Maya Dajee
P2860
P304
P356
10.1136/GUT.2006.096487
P407
P577
2006-09-01T00:00:00Z